Head and Neck Neuroendocrine Neoplasm — Trials

Head and Neck Neuroendocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03037385	Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors(ARROW)	completed	Phase 1 / Phase 2	590	Hoffmann-La RocheINDUSTRY	13	May 31, 2025	clinicaltrials
NCT00381641	Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery	completed	Phase 2	63	National Cancer Institute (NCI)NIH